Neuromuscular Disorders in Hyderabad:
When the Problem Is in the Nerve, the Junction, or the Muscle — Accurate Diagnosis Changes Everything

These terms describe where in the neuromuscular system the problem lies. A neuropathy is a disease of the peripheral nerves — the problem is in the electrical cable carrying the signal from the spinal cord to the muscle. A myopathy is a disease of the muscle itself — the cable is intact, but the machine it connects to is damaged. In practice, the distinction shows up in the pattern of weakness: neuropathies typically cause distal weakness (hands and feet first), while myopathies cause proximal weakness (hips, thighs, and shoulders first). Both NCS and EMG at KIMS are essential — neither can be reliably distinguished from clinical examination alone.

The movement you are describing is called Gower's sign — a classic indicator of proximal muscle weakness in children, particularly weakness of the hip extensors and quadriceps. In a child, Gower's sign raises immediate concern for a muscular dystrophy — most commonly Duchenne Muscular Dystrophy in boys, or a Limb-Girdle Muscular Dystrophy in either sex — or for Spinal Muscular Atrophy. Please bring your child to KIMS Neuroscience urgently — call 040-44885000. A serum CK blood test and referral for NCS/EMG should be the first steps, followed by genetic testing. In Duchenne Muscular Dystrophy, early steroid treatment significantly slows disease progression.

Drooping eyelids (ptosis) combined with swallowing difficulty (dysphagia) in the absence of other stroke signs is far more suggestive of a neuromuscular junction disorder — particularly Myasthenia Gravis — than a stroke. In Myasthenia Gravis, these symptoms characteristically fluctuate: worse in the evening, better after rest, possibly triggered by physical activity, heat, or infection. Please come to KIMS Neuroscience urgently — call 040-44885000. An AChR antibody test, repetitive nerve stimulation study, and CT chest will be performed. If your swallowing is severely affected or breathing is laboured — call 040-46324365 immediately, as this may represent a myasthenic crisis.

A myasthenic crisis is a life-threatening worsening of Myasthenia Gravis in which the respiratory muscles become too weak to sustain adequate breathing. Triggers include infection, missed medication, certain antibiotics (quinolones, aminoglycosides), and initial steroid worsening. Treatment at KIMS includes: respiratory monitoring and ventilatory support, immediate IVIG or plasmapheresis to rapidly reduce circulating antibodies, and identification of the triggering cause. Myasthenic crisis carries significant mortality if managed outside a specialist centre without Neuro-ICU capability. KIMS has dedicated neuromuscular ICU protocols for this emergency — call 040-46324365.

Duchenne Muscular Dystrophy is caused by mutations in the dystrophin gene on the X chromosome — an X-linked recessive condition. If your son has DMD, there is a 50% chance that each future son will be affected, and a 50% chance that each future daughter will be a carrier. Prenatal genetic testing and pre-implantation genetic diagnosis (PGD) are options discussed at a genetic counselling consultation at KIMS. Approximately one-third of DMD cases arise from new mutations — meaning the mother is not a carrier — so genetic testing of the mother is the first step in clarifying recurrence risk. Call 040-44885000 to arrange a genetics referral.

Yes — and the treatment landscape for SMA has changed fundamentally in the last five years. Nusinersen (Spinraza) and risdiplam (Evrysdi) are both disease-modifying therapies that slow or halt SMA progression by increasing survival motor neuron protein production. Both are approved in India. The critical issue is timing: most SMA diagnoses in India are made only when the patient is over 2 years of age — by which time significant motor neuron loss has already occurred. The earlier treatment begins, the greater the benefit. Access support for both medications is available through manufacturer programmes. KIMS can provide guidance on the access process — call 040-44885000 for an urgent SMA assessment.

Yes — direct neuromuscular appointments are accepted. Outpatient: 040-44885000 (Mon–Sat). If you have prior CK levels, NCS/EMG reports, antibody tests, MRI, muscle biopsy slides, or genetic test results, please bring them — they make the first assessment much more efficient. For acute respiratory distress or rapidly progressing weakness, call 040-46324365 immediately — the neuro-ICU activates on the call.